The role of pelvine lymphadenectomy in prostate cancer;Stellenwert der pelvinen lymphadenektomie beim klinisch lokalisierten prostatakarzinom

Urologe - Ausgabe A

Volumn 44, Issue 6, 2005, Pages 645-651

  Schumacher, M ^a   Burkhard, F C ^a   Studer, U E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Lymph node metastasis; Prostate cancer; Radical prostatectomy

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; ILIAC VEIN; LYMPH NODE DISSECTION; METASTASIS; PELVIS LYMPHADENECTOMY; PROSTATE CANCER; PROSTATECTOMY; RELIABILITY;

CLINICAL TRIALS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PELVIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREOPERATIVE CARE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 23444447664     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-005-0828-2     Document Type: Article

References (45)

1. Mathiesen O, Carl J, Bonderup O et al. (1990) Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 29: 721-725
2. Siewert JR, Böttcher K, Stein HJ et al. (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228: 449-461
3. Friedberg V (1989) Results of 108 exenteration operations in advanced gynecologic cancers. Geburtshilfe Frauenheilkd 49: 423-427
4. Caplin S, Cerottini JP, Bosman FT et al. (1998) For patients with Duke's B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 82: 666-672
5. Mills RD, Turner WH, Fleischmann A et al. (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166: 19-23
6. Leissner J, Hohenfellner R, Thüroff JW et al. (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Br J Urol 85: 817-823
7. Partin AW, Mangold LA, Lamm DM et al (2001) Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58: 843-848
8. Wolf JS Jr, Cher M, Dallera M et al. (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153: 993-999
9. Paik ML, Scolieri MJ, Brown SL et al. (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163: 1693-1696
10. Tempany CM, McNeil BJ (2001) Advances in biomedical imaging. Jama 285: 562-567
11. Wawroschek F, Vogt H, Wengenmair H et al. (2003) Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70: 303-310
12. Bader P, Burkhard FC, Markwalder R et al. (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168: 514-518
13. Weingaertner K, Ramaswamy A, Bittinger A et al. (1996) Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156: 1969-1971
14. Stone NN, Stock RG, Unger P (1997) Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J Urol 158: 1891-1894
15. Heidenreich A, Von Knobloch R, Varga Z et al. (2004) Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy (RRP) - an update on >300 cases. J Urol A 171(312): 1183
16. Bluestein DL, Bostwick DG, Bergstralh EJ et al. (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315-1320
17. Petros JA, Catalona WJ (1992) Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147: 1574-1575
18. Bishoff JT, Reyes A, Thompson IM et al. (1995) Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45: 270-274
19. Heidenreich A, Varga Z, Von Knobloch R (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167: 1681-1686
20. Tenaglia JL, Iannucci M (2004) Extended pelvic lymphadenetomy for the treatment of localized prostate carcinoma. Europ Urol Today 15
21. Clark T, Parekh DJ, Cookson MS et al. (2003) Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169: 145-148
22. Link RE, Morton RA (2001) Indications for pelvic lymphadenectomy in prostate cancer. Urol Clin North Am 28: 491-498
23. Burkhard FC, Schumacher M, Thalmann GN et al. (2005) Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 95: 275-278
24. Jhaveri FM, Zippe CD, Klein EA et al. (1999) Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. Urology 54: 884-890
25. Han M, Partin AW, Pound CR et al. (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28: 555-565
26. Bader P, Burkhard FC, Markwalder R et al. (2003) Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169: 849-854
27. Roehl KA, Han M, Ramos CG et al. (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172: 910-914
28. Steinberg GD, Epstein JI, Piantadosi S et al. (1990) Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144: 1425-1432
29. Sgrignoli AR, Walsh PC, Steinberg GD et al. (1994) Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol 152: 1077-1081
30. deKernion JB, Neuwirth H, Stein A et al. (1990) Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J Urol 144: 700-703
31. Zwergel U, Lehmann J, Wullich B et al. (2004) Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 171: 1128-1131
32. Frazier HA 2nd, Robertson JE, Paulson DF (1994) Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? World J Urol 12: 308-312
33. Cadeddu JA, Partin AW, Epstein JI et al. (1997) Stage D1 (T1-3, N1-3, MO) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology 50: 251-255
34. Messing E, Manola J, Sarosdy M et al. (2003) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer. Results at 10 years of EST 3886. J Urol 169: 396
35. Catalona WJ, Miller DR, Kavoussi LR (1988) Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 140: 540-543
36. Pound CR, Partin AW, Eisenberger MA et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. Jama 281: 1591-1597
37. Golimbu M, Morales P, Al-Askari S et al. (1979) Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121: 617-620
38. Bader P, Spahn M, Huber R et al. (2004) Limited lymph node dissection in prostate cancer may miss lymph node metastasis and determines outcome of apparently pN0 prostate cancer. Eur Urol A 3(16): 55
39. Daneshmand S, Quek ML, Stein JP et al. (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172: 2252-2255
40. Allaf ME, Palapattu GS, Trock BJ et al. (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172: 1840-1844
41. Dimarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML (2005) The extent of lymphadenectomy for pTXN0 prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173: 1121-1125
42. Di Blasio CJ, Fearn P, Seo HS et al. (2003) Association between number of lymph npdes removed and freedom from disease progression in patients receiving pelvic lymph node dissection during radical prostatectomy. J Urol A 169(456): 1708
43. Palapattu GS, Allaf ME, Trock BJ et al. (2004) Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 172: 1860-1864
44. Holmberg L, Bill-Axelson A, Helgesen F et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347: 781-789
45. Hull GW, Rabbani F, Abbas F et al. (2002) Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167: 528-534